What You Should Know: - Proscia secures $23M in Series B funding led by Scale Venture Partners for its AI-enabled digital pathology solutions. - Proscia will use the funding to expand its AI application portfolio, boost commercial expansion, and advance its regulatory strategy to secure FDA approval. Proscia, a Philadelphia-based provider of digital and computational pathology solutions, today announced it has secured $23M in Series B funding led by Scale Venture
Read More
Proscia
JPC Taps Proscia to Modernize World’s Largest Human Tissue Repository
What You Should Know: - The U.S. government’s Joint Pathology Center, which houses the world’s largest human tissue repository, today announced that Proscia, a leading digital and AI pathology company, will provide end-to-end modernization of JPC’s pathology operations. - The multi-phase project will digitize the world’s largest human pathology specimen repository in order to enhance biomedical research for cancer and infectious diseases like COVID-19, and enable easier data sharing with
Read More
Philips Partners With Proscia to Accelerate Open Digital Pathology Adoption
What You Should Know: - Philips inks a collaboration with digital pathology leader Proscia to advance an open ecosystem that helps laboratories accelerate and scale digital pathology adoption. - Proscia will integrate the Philips Pathology SDK to natively utilize Philips’ iSyntax image format with its Concentriq digital pathology platform and suite of AI modules, providing users of Philips’ digital pathology solutions with expanded options to meet their business and
Read More
CB Insights Unveils ‘Digital Health 150’ List of Startups Transforming Healthcare
- CB Insights unveils first-ever annual ‘Digital Health 150’ list of digital health startups working to transform the healthcare industry. - The Digital Health 150 companies span a wide spectrum of categories that involve all three key stakeholder groups for the healthcare industry — providers, payers, and patients. - A total of 17 companies on the list are unicorns (private companies valued at $1B+). Of these, 12 companies are US-based, 3 are based in China, 1 is based in France, and 1
Read More
Proscia Raises $8M for AI-Enhanced Digital Pathology for Cancer Diagnosis
Proscia, a Philadelphia-based digital pathology platform has raised $8.3 million in Series A funding led by Boston-based Flybridge Capital Partners with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures, and RobinHood Ventures.The startup plans to utilize the Series A funding to fuel the development and commercialization of new, clinical AI-enabled workflows targeting high-volume, high-impact cancers, the first of which will be available later this year. In
Read More
